Correlation analysis for alterations of intestinal flora in hepatocellular carcinoma patients: combinatorial detection of Coriobacterium, Atopobium, Coprococcus and Veillonella dispar may be a new method for HCC diagnosis.

IF 2.4 4区 医学 Q3 MICROBIOLOGY
Wenqian Xu, Yan Jiang, Jinglong Tao, Yunhong Liu, Yongwu Xia, Cheng Chen, Xiaoxin Jiang
{"title":"Correlation analysis for alterations of intestinal flora in hepatocellular carcinoma patients: combinatorial detection of <i>Coriobacterium</i>, <i>Atopobium</i>, <i>Coprococcus</i> and <i>Veillonella dispar</i> may be a new method for HCC diagnosis.","authors":"Wenqian Xu,&nbsp;Yan Jiang,&nbsp;Jinglong Tao,&nbsp;Yunhong Liu,&nbsp;Yongwu Xia,&nbsp;Cheng Chen,&nbsp;Xiaoxin Jiang","doi":"10.1099/jmm.0.001713","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction.</b> Hepatocellular carcinoma (HCC) is one of the most common malignant tumours in the world. Due to the characteristics of low early diagnosis rate, high malignancy and rapid progression, the majority of diagnosed patients are in the middle or late stage. Accumulating evidence reveals that intestinal flora imbalance will aggravate HCC by disturbing immune regulation, especially interleukin expression. Therefore, intestinal flora-based methods have the potential to be new diagnostic or therapeutic methods for HCC.<b>Hypothesis.</b> Compositions of intestinal florae were different between HCC patients and healthy people. Further, intestinal florae may alleviate or aggravate HCCs.<b>Methods.</b> To determine which intestinal florae and interleukin aggravate HCCs, we studied the differences in intestinal florae composition and interleukin (IL) indices between HCC patients and healthy people. A total of 64 HCC patients and 24 healthy people were recruited, and their fresh stool samples and serum samples were collected for 16S rRNA sequencing and metabolite index measurement.<b>Results.</b> Data showed that 484 operational taxonomic units (OTUs) and 476 OTUs were detected in the HCC and control groups, respectively. From the phylum level to the species level, 5, 6, 10, 15, 23 and 19 colonies showed differential abundance between the HCC group and healthy people. Moreover, interleukin-6 expression and interleukin-10 expression were significantly different between two groups. Of note, differences of <i>Coriobacterium</i>, <i>Atopobium</i> and <i>Coprococcus</i> at genus level and <i>Veillonella dispar</i> at species level in two groups were significantly related to IL-6 and IL-10.<b>Conclusion.</b> The abundance of intestinal florae in the HCC group was different from the control group. Additionally, combinatorial detection of <i>Coriobacterium</i>, <i>Atopobium</i> and <i>Coprococcus</i> at genus level and <i>V. dispar</i> at species level may be a new method for HCC diagnosis.</p>","PeriodicalId":16343,"journal":{"name":"Journal of medical microbiology","volume":"72 6","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical microbiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1099/jmm.0.001713","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction. Hepatocellular carcinoma (HCC) is one of the most common malignant tumours in the world. Due to the characteristics of low early diagnosis rate, high malignancy and rapid progression, the majority of diagnosed patients are in the middle or late stage. Accumulating evidence reveals that intestinal flora imbalance will aggravate HCC by disturbing immune regulation, especially interleukin expression. Therefore, intestinal flora-based methods have the potential to be new diagnostic or therapeutic methods for HCC.Hypothesis. Compositions of intestinal florae were different between HCC patients and healthy people. Further, intestinal florae may alleviate or aggravate HCCs.Methods. To determine which intestinal florae and interleukin aggravate HCCs, we studied the differences in intestinal florae composition and interleukin (IL) indices between HCC patients and healthy people. A total of 64 HCC patients and 24 healthy people were recruited, and their fresh stool samples and serum samples were collected for 16S rRNA sequencing and metabolite index measurement.Results. Data showed that 484 operational taxonomic units (OTUs) and 476 OTUs were detected in the HCC and control groups, respectively. From the phylum level to the species level, 5, 6, 10, 15, 23 and 19 colonies showed differential abundance between the HCC group and healthy people. Moreover, interleukin-6 expression and interleukin-10 expression were significantly different between two groups. Of note, differences of Coriobacterium, Atopobium and Coprococcus at genus level and Veillonella dispar at species level in two groups were significantly related to IL-6 and IL-10.Conclusion. The abundance of intestinal florae in the HCC group was different from the control group. Additionally, combinatorial detection of Coriobacterium, Atopobium and Coprococcus at genus level and V. dispar at species level may be a new method for HCC diagnosis.

肝癌患者肠道菌群变化的相关性分析:联合检测Coriobacterium、Atopobium、Coprococcus和Veillonella dispar可能是HCC诊断的新方法。
介绍。肝细胞癌是世界上最常见的恶性肿瘤之一。由于早期诊断率低、恶性程度高、进展快等特点,确诊患者多处于中晚期。越来越多的证据表明,肠道菌群失调会通过干扰免疫调节,尤其是白细胞介素的表达而加重HCC。因此,基于肠道菌群的方法有可能成为hcc的新的诊断或治疗方法。肝细胞癌患者肠道菌群组成与健康人不同。此外,肠道菌群可减轻或加重hccs。为了确定哪些肠道菌群和白细胞介素加重了HCC,我们研究了HCC患者和健康人肠道菌群组成和白细胞介素(IL)指数的差异。共招募64例HCC患者和24例健康人,采集其新鲜粪便样本和血清样本,进行16S rRNA测序和代谢物指数测定。数据显示,HCC组和对照组分别检测到484个和476个操作分类单位(otu)。从门水平到种水平,HCC组与健康人有5、6、10、15、23和19个菌落丰度差异。此外,白细胞介素-6和白细胞介素-10的表达在两组之间也有显著差异。值得注意的是,两组在属水平上的Coriobacterium、Atopobium和Coprococcus的差异以及在种水平上的Veillonella dispar的差异与IL-6和il -10显著相关。肝细胞癌组肠道菌群丰度与对照组不同。此外,在属水平上联合检测Coriobacterium、Atopobium和Coprococcus,在种水平上联合检测V. dispar可能是HCC诊断的新方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of medical microbiology
Journal of medical microbiology 医学-微生物学
CiteScore
5.50
自引率
3.30%
发文量
143
审稿时长
4.5 months
期刊介绍: Journal of Medical Microbiology provides comprehensive coverage of medical, dental and veterinary microbiology, and infectious diseases. We welcome everything from laboratory research to clinical trials, including bacteriology, virology, mycology and parasitology. We publish articles under the following subject categories: Antimicrobial resistance; Clinical microbiology; Disease, diagnosis and diagnostics; Medical mycology; Molecular and microbial epidemiology; Microbiome and microbial ecology in health; One Health; Pathogenesis, virulence and host response; Prevention, therapy and therapeutics
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信